HEPACAM and myeloid sarcoma: Autoantibodies against anoctamin-2 (an ion channel expressed in the CNS) or GlialCAM (a component of glial cells in the brain) can recognize the fragment of EBV nuclear antigen 1, and they were increased in MS patients [63,64].